Published in
Taylor and Francis Group, Expert Review of Pharmacoeconomics and Outcomes Research, 6(20), p. 653-659, 2019
DOI: 10.1080/14737167.2019.1667232
Links
Tools
Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary
Journal article published in 2019 by
András Harsányi,
Marcell Csanádi 
,
Kristóf Márky,
Áron Zoltán Vincziczki,
Zoltán Kaló ,
András Inotai
,
Kristóf Márky,
Áron Zoltán Vincziczki,
Zoltán Kaló ,
András Inotai
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 